Heike Hellmold

790 citations

19 papers · 618 indexed · h-index 13

Impact in

Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Health, Toxicology and Mutagenesis top 10%
- Toxic Organic Pollutants Impact
- Effects and risks of endocrine disrupting chemicals

Papers in ⓘ

Molecular Biology 9
- Peroxisome Proliferator-Activated Receptors 4
Pharmacology 5
- Pharmacogenetics and Drug Metabolism 5

Co-authors: Margaret Warner (5 shared papers)Jan-Ακε Gustafsson (4 shared papers)Ian A. Cotgreave (3 shared papers)Kerstin Nilsson (2 shared papers)Jan Andersson (6 shared papers)Helen Håkansson (2 shared papers)Charlotte B. Nilsson (2 shared papers)Nick Fletcher (1 shared paper)
Journals: Toxicologic Pathology (3 papers)Toxicology and Applied Pharmacology (3 papers)Molecular Pharmacology (2 papers)Toxicological Sciences (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
Partner nations: Sweden United Kingdom United States

In The Last Decade

Heike Hellmold

19 papers receiving 600 citations

Peers

Countries citing papers authored by Heike Hellmold

Since Specialization

Citations

This map shows the geographic impact of Heike Hellmold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Hellmold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Hellmold more than expected).

Fields of papers citing papers by Heike Hellmold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Hellmold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Hellmold. The network helps show where Heike Hellmold may publish in the future.

Co-authors

The 25 scholars most cited alongside Heike Hellmold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heike Hellmold Line = papers co-authored together Heike Hellmold links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: A microarray study Toxicology and Applied Pharmacology ·Nick Fletcher, David Wahlström, Rebecca Lundberg, Charlotte B. Nilsson, Kerstin Nilsson, Kenneth Stockling, Heike Hellmold, Helen Håkansson	2005	139
2	Isoforms of alanine aminotransferases in human tissues and serum—Differential tissue expression using novel antibodies Archives of Biochemistry and Biophysics ·Per Henrik Lindblom, Ingalill Rafter, C G Copley, Jan Andersson, Jesper J. Hedberg, Anna‐Lena Berg, Anders Samuelsson, Heike Hellmold, Ian A. Cotgreave, Björn Glinghammar	2007	81
3	Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction Mammaplasties¹ The Journal of Clinical Endocrinology & Metabolism ·Heike Hellmold, Tove Rylander, Malin Magnusson, Eva Reihnér, Margaret Warner, Jan-Ακε Gustafsson	1998	70
4	The transcriptosomal response of human A549 lung cells to a hydrogen peroxide-generating system: relationship to DNA damage, cell cycle arrest, and caspase activation Free Radical Biology and Medicine ·Tiziana Dandrea, Heike Hellmold, Carina Jonsson, Boris Zhivotovsky, Tim Hofer, Lars Wärngård, Ian A. Cotgreave	2004	55
5	PPARα regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes Toxicology and Applied Pharmacology ·Petra Thulin, Ingalill Rafter, Kenneth Stockling, Céline Tomkiewicz, Ensio Norjavaara, Μartine Aggerbeck, Heike Hellmold, Ewa Ehrenborg, Jan Andersson, Ian A. Cotgreave, Björn Glinghammar	2008	51
6	Correlation network analysis for data integration and biomarker selection Molecular BioSystems ·Aram Adourian, Ezra G. Jennings, Raji Balasubramanian, Wade Hines, Doris Damian, Thomas N. Plasterer, Clary B. Clish, Paul Stroobant, Robert McBurney, Elwin Verheij, I. Bobeldijk, J. van der Greef, Johan Lindberg, Kerstin Kenne, Jan Andersson, Heike Hellmold, Kerstin Nilsson, Hugh Salter, Ina Schuppe‐Koistinen	2008	41
7	Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism Cardiovascular Research ·Christian Danielsson, Johan Brask, Anna‐Carin Sköld, Rami Genead, Agneta Andersson, Jan Andersson, Kenneth Stockling, Rickard Pehrson, Karl‐Henrik Grinnemo, Sajjad Salari, Heike Hellmold, Bengt Danielsson, Christer Sylvén, Fredrik Elinder	2012	31
8	Tesaglitazar, a PPARα/γ Agonist, Induces Interstitial Mesenchymal Cell DNA Synthesis and Fibrosarcomas in Subcutaneous Tissues in Rats Toxicological Sciences ·Heike Hellmold, Hui Zhang, Jan Andersson, Bo Blomgren, Tom Holland, Anna‐Lena Berg, Marie Elebring, Niclas Sjögren, Krister Bamberg, Björn Dahl, R.B. Westerberg, Birgitta Dillnér, Jonathan Tugwood, Ruth Roberts, Erik Lundholm, Germán Camejo, Inger Skånberg, J.G. Evans	2007	28
9	Developmental and endocrine regulation of P450 isoforms in rat breast. Molecular Pharmacology ·Heike Hellmold, John G. Lamb, Adrian Wyss, Jan Gustafsson, Margaret Warner	1995	27
10	Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines Carcinogenesis ·Heike Hellmold, Eva Övervik, Maria Strömstedt, Jan-Ακε Gustafsson	1993	21
11	Cytochrome P450 in the breast and brain: role in tissue-specific activation of xenobiotics Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Margaret Warner, Heike Hellmold, Shigetaka Yoshida, D. Joshua Liao, Eva Hedlund, Jan-Ακε Gustafsson	1997	20
12	Early Stellate Cell Activation and Veno-occlusive-disease (VOD)–like Hepatotoxicity in Dogs Treated with AR-H047108, an Imidazopyridine Proton Pump Inhibitor Toxicologic Pathology ·Anna‐Lena Berg, Gerhard Böttcher, Kjell Andersson, Enar Carlsson, Anna-Karin Lindström, R. Huby, Helen Håkansson, Inger Skånberg-Wilhelmsson, Heike Hellmold	2008	19
13	Identification of CYP2A3 as a Major Cytochrome P450 Enzyme in the Female Peripubertal Rat Breast Molecular Pharmacology ·Heike Hellmold, Malin Magnusson, Markku Pelto‐Huikko, Tove Rylander, Jan-Ακε Gustafsson, Margaret Warner	1998	12
14	Identification of end points relevant to detection of potentially adverse drug reactions Toxicology Letters ·Heike Hellmold, Charlotte B. Nilsson, Ina Schuppe‐Koistinen, Kerstin Kenne, Lars Wärngård	2002	8
15	Tesaglitazar, a Dual PPAR-α/γ Agonist, Hamster Carcinogenicity, Investigative Animal and Clinical Studies Toxicologic Pathology ·Per Henrik Lindblom, Anna‐Lena Berg, Hui Zhang, R.B. Westerberg, Jonathan Tugwood, Hanna Lundgren, Maritha Marcusson‐Ståhl, Niclas Sjögren, Bo Blomgren, Peter Öhman, Inger Skånberg, J.G. Evans, Heike Hellmold	2011	5
16	Extrahepatic Cytochrome P450: Role in In Situ Toxicity and Cell-Specific Hormone Sensitivity Archives of toxicology. Supplement ·Margaret Warner, Heike Hellmold, Malin Magnusson, Tove Rylander, Eva Hedlund, Jan‐Åke Gustafsson	1998	4
17	Proliferative and Molecular Effects of the Dual PPARα/γ Agonist Tesaglitazar in Rat Adipose Tissues: Relevance for Induction of Fibrosarcoma Toxicologic Pathology ·Björn Glinghammar, Anna‐Lena Berg, Sivert Bjurström, Kenneth Stockling, Bo Blomgren, R.B. Westerberg, Inger Skånberg, Heike Hellmold, Jan Andersson	2011	3
18	Activation and effects of the food-derived heterocyclic amines in extrahepatic tissues. PubMed ·Eva Övervik, Heike Hellmold, Christina Branting, Gustafsson Ja	1995	2
19	Comparative effects of sodium channel blockers in short term rat whole embryo culture Toxicology and Applied Pharmacology ·Mats Nilsson, Anna‐Carin Sköld, Ann-Christin Ericson, Anita Annas, Rodrigo Palma Villar, Gvido Cebers, Heike Hellmold, Anne-Lee Gustafson, William S. Webster	2013	1

About Heike Hellmold

Heike Hellmold is a scholar working on Molecular Biology, Pharmacology, Oncology, Cancer Research and Genetics, having authored 19 papers that have together received 618 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Estrogen and related hormone effects (3 papers), Chemical Reactions and Isotopes (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Pharmacology (173 citations), Health, Toxicology and Mutagenesis (116 citations), Cancer Research (121 citations), Hepatology (40 citations) and Biochemistry (34 citations). Heike Hellmold has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Margaret Warner, Jan-Ακε Gustafsson, Ian A. Cotgreave, Kerstin Nilsson, Jan Andersson, Helen Håkansson, Charlotte B. Nilsson, Nick Fletcher, Rebecca Lundberg and Malin Magnusson. Their work appears in journals such as Toxicologic Pathology, Toxicology and Applied Pharmacology, Molecular Pharmacology, Toxicological Sciences and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact